CorMedix (CRMD) Non Operating Investment Income (2015 - 2025)

CorMedix (CRMD) reported Non Operating Investment Income of $2.3 million for Q4 2025, down 26.46% sequentially from $3.1 million in Q3 2025.

CorMedix (CRMD) Non Operating Investment Income (2015 - 2025) Analysis & Trends

CorMedix (CRMD) has 6 years of Non Operating Investment Income data on file, last reported at $2.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Investment Income changed N/A year-over-year to $2.3 million; the trailing twelve-month figure through Dec 2025 stood at $5.4 million (changed N/A YoY), and the FY2025 full-year result was $5.4 million, changed N/A from the prior year.
  • Non Operating Investment Income fell to $2.3 million in Q4 2025, from $3.1 million in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $3.1 million in Q3 2025 to a low of $2.3 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 CorMedix 4.95 Mn -150.26 Mn 107.31 Mn 2.27 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.27 Mn
Dec 31, 2025 2.27 Mn
Sep 30, 2025 3.09 Mn
Sep 30, 2025 3.09 Mn
Mar 31, 2020 5,633.00
Mar 31, 2020 5,633.00
Dec 31, 2019 -4,446.00
Dec 31, 2019 -4,446.00
Sep 30, 2019 -3,125.00
Sep 30, 2019 -3,125.00
Jun 30, 2019 8,846.00
Jun 30, 2019 8,846.00
Mar 31, 2019 -1,008.00
Mar 31, 2019 -1,008.00
Dec 31, 2017 90.00
Dec 31, 2017 90.00
Sep 30, 2017 2,600.00
Sep 30, 2017 2,600.00
Jun 30, 2017 300.00
Jun 30, 2017 300.00